Contractor Notice: Further extension and amendment to SSP02 only

Contractor Notice: Further extension and amendment to SSP02 only

November 20, 2019

The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Fluoxetine capsules.

The SSP for Fluoxetine 30mg capsules has been extended with a change to an alternative product (please check updated SSP02 protocol before dispensing), whilst the SSP for Fluoxetine 40mg capsules expired 20th November 2019.

SSP02 for Fluoxetine 30mg capsules

This has been further extended with a revised expiry date now set as 18th December 2019.

An amendment to the SSP also means that pharmacists who decide it is appropriate to follow the protocol must now supply Fluoxetine 10mg capsules instead of tablets – i.e. for every Fluoxetine 30mg capsule supply: 1 x Fluoxetine 10mg capsule, plus 1 x Fluoxetine 20mg capsule.

SSP03 for Fluoxetine 40mg capsules

SSP03 has now expired effective 20 November 2019 as sufficient stock is now available to supply normal demand for dispensing against prescriptions for Fluoxetine 40mg capsules. SSP03 is therefore no longer valid for use and any prescriptions presented for Fluoxetine 40mg must be dispensed in accordance with the original prescription.

Summary

SSP & Product Current expiry date Notes
SSP02: Fluoxetine 30mg capsules This SSP has been varied – the revised end date is now 18th December 2019

New directions state the pharmacist must now supply Fluoxetine 10mg capsules plus Fluoxetine 20mg capsules

(This SSP previously stated that Fluoxetine 10mg tablets plus Fluoxetine 20mg capsules must be provided.)

SSP03: Fluoxetine 40mg capsules This SSP expired 20th November 2019
SSP01: Fluoxetine 10mg capsules This SSP expired 25th October 2019

Top Tips

  • View our SSP submission reminder to ensure your SSP claims are appropriately submitted to NHSBSA  for reimbursement.
  • Ensure that the dispensed notification messages for all EPS SSP claims are submitted before midnight on the 20th November.
  • Pharmacy teams are advised to submit SSP claims using the EPS token if your PMR systems do not support/capture all the SSP endorsement requirements for a valid claim.
  • If using a token to submit SSP claims, to avoid double-claiming, remember to mark the item covered by the SSP as ‘Not Dispensed’/’ND’ on the EPS message.
  • Where available, use the claim amend facility on your PMR system to rectify any incorrect EPS claims already submitted this month.
  • Any paper prescriptions or tokens with SSP claims need to be placed in a red separator (and kept separate from other tokens for non-payment i.e. with paid/exempt status).
  • Check that the correct number of patient charges are collected and declared on the end of month FP34C submission form.
  • SSPs will be accepted for up to three calendar months after expiry or withdrawal of the SSP. For example, for the Fluoxetine 30mg capsules SSP, which was withdrawn on 20th November, the NHSBSA would look for the “NCSO” endorsement in the November batch (submitted by the 5th of December), December batch (submitted by the 5th January) and January batch (submitted by the 5th of February).
  • NHSBSAs advise that contractor SSP claims should be clear and unambiguous and follow the protocol guidelines – NHSBSA processing staff must be able to determine what has been supplied.

FAQ

Q. Can I supply Fluoxetine 10mg tablets and Fluoxetine 20mg capsules for SSP02 (Fluoxetine 30mg capsules) after 20th November 2019?

A. No. SSP02 was amended so that after 20th November, contractors will only be able to supply a combination of 1 x Fluoxetine 10mg capsules and 1 x Fluoxetine 20mg capsules. Fluoxetine 10mg tablets can no longer be supplied against SSP02 after the 20th November. Before issuing an SSP check the up-to date SSP protocol here.

Additional information

On 3rd October 2019 it was announced that the Secretary of State had authorised three Serious Shortage Protocols (SSPs) to help manage the supply of some formulations of Fluoxetine. These SSPs were put in place to manage stock and to try to ensure that fewer patients have to return to their prescriber.

View PSNC’s support guidance to endorsing Fluoxetine SSPs here.

View PSNC’s SSP FAQ page here.

View NHSBSA’s support guidance to endorsing Fluoxetine SSPs here.

To view the latest SSP updates visit: www.nhsbsa.nhs.uk/pharmacies-gp-practices-andappliance-contractors/serious-shortage-protocols-ssps



Posted in: ,


More Latest News >